TURN THERAPEUTICS INC (TTRX) Stock Income Statement
NASDAQ:TTRX • US90021W1053
Current stock price
3.56 USD
-0.04 (-1.11%)
Last:
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | N/A | N/A | 0.00 | |||
| Gross Profit | N/A | N/A | 0.00 | |||
| Operating Expenses | 1.80M | 2.31M | 4.21M | |||
| Research and Development | 246.00K | 7.50K | N/A | |||
| Selling, General, and Administrative Expenses | 1.50M | 2.26M | 4.16M | |||
| Operating Income | -1.80M | -2.31M | -4.21M | |||
| Interest Income/Expense | 28.70K | 15.90K | -85.40K | |||
| Other Income/Expense | N/A | N/A | 9.10K | |||
| Income Before Taxes | -1.77M | -2.29M | -4.29M | |||
| Income Tax | N/A | N/A | 800.00 | |||
| Net Income | -1.77M | -2.29M | -4.29M | |||
| EBITDA | -1.75M | -2.25M | -4.16M | |||
| Per Share Data | ||||||
| EPS Diluted Total Ops | -0.06 | -0.08 | -0.15 | |||
| Statistics | ||||||
All data in USD